Standing up to the cardiometabolic consequences of hematological cancers
Hematological cancer survivors are highly vulnerable to cardiometabolic complications impacting long-term health status, quality of life and survival. Elevated risk of diabetes and cardiovascular disease arises not only from the effects of the cancers themselves, but also from the toxic effects of cancer therapies, and deconditioning arising from reduced physical activity levels. Regular physical activity can circumvent or reverse adverse effects on the heart, skeletal muscle, vasculature and blood cells, through a combination of systemic and molecular mechanisms.
Source: Blood Reviews - Category: Hematology Authors: Erin J. Howden, Andr é La Gerche, Jane F. Arthur, Julie R. McMullen, Garry L. Jennings, David W. Dunstan, Neville Owen, Sharon Avery, Bronwyn A. Kingwell Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Hematology | Toxicology